AlphaMark Advisors’s BioDelivery Sciences International, Inc. BDSI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-400
| Closed | -$1K | – | 666 |
|
|
2021
Q4 | $1K | Hold |
400
| – | – | ﹤0.01% | 572 |
|
|
2021
Q3 | $1K | Sell |
400
-500
| -56% | -$1.89K | ﹤0.01% | 573 |
|
|
2021
Q2 | $3K | Hold |
900
| – | – | ﹤0.01% | 505 |
|
|
2021
Q1 | $4K | Sell |
900
-200
| -18% | -$826 | ﹤0.01% | 473 |
|
|
2020
Q4 | $5K | Hold |
1,100
| – | – | ﹤0.01% | 424 |
|
|
2020
Q3 | $4K | Hold |
1,100
| – | – | ﹤0.01% | 460 |
|
|
2020
Q2 | $5K | Hold |
1,100
| – | – | ﹤0.01% | 440 |
|
|
2020
Q1 | $4K | Hold |
1,100
| – | – | ﹤0.01% | 412 |
|
|
2019
Q4 | $7K | Hold |
1,100
| – | – | ﹤0.01% | 381 |
|
|
2019
Q3 | $5K | Hold |
1,100
| – | – | ﹤0.01% | 403 |
|
|
2019
Q2 | $5K | Hold |
1,100
| – | – | ﹤0.01% | 425 |
|
|
2019
Q1 | $6K | Hold |
1,100
| – | – | ﹤0.01% | 391 |
|
|
2018
Q4 | $4K | Hold |
1,100
| – | – | ﹤0.01% | 412 |
|
|
2018
Q3 | $3K | Hold |
1,100
| – | – | ﹤0.01% | 464 |
|
|
2018
Q2 | $3K | Hold |
1,100
| – | – | ﹤0.01% | 476 |
|
|
2018
Q1 | $2K | Hold |
1,100
| – | – | ﹤0.01% | 488 |
|
|
2017
Q4 | $3K | Hold |
1,100
| – | – | ﹤0.01% | 465 |
|
|
2017
Q3 | $3K | Hold |
1,100
| – | – | ﹤0.01% | 462 |
|
|
2017
Q2 | $3K | Hold |
1,100
| – | – | ﹤0.01% | 473 |
|
|
2017
Q1 | $2K | Buy |
1,100
+500
| +83% | +$964 | ﹤0.01% | 472 |
|
|
2016
Q4 | $1K | Buy |
+600
| New | +$1.23K | ﹤0.01% | 454 |
|
Other funds holding BDSI
AlphaMark Advisors's BDSI Position: Q1 2022 in Review
AlphaMark Advisors sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 400 shares — an estimated $1K sold.
AlphaMark Advisors first reported a position in BDSI in Q4 2016 and held it in 21 quarters. The position peaked at $7K in Q4 2019. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.
- AlphaMark Advisors reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
- AlphaMark Advisors sold 400 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $1K.
- AlphaMark Advisors first reported a position in BioDelivery Sciences International, Inc. in Q4 2016 and held it in 21 quarters.
- AlphaMark Advisors's BioDelivery Sciences International, Inc. position peaked at $7K in Q4 2019.
- 2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.
Based on AlphaMark Advisors's 13F filing for Q1 2022, filed 2 May 2022.